Skip to content
value.today

NUON Therapeutics Inc.

Total raised
$30 M
3 rounds on record
Latest round
$10 M
Aug 2010
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of NUON Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2010$10 MNo. 3$10 to $50 million

NUON Therapeutics Inc.: Raise no. 3, Aug 2010

Investors in this round

9 investors had bought by the notice of Aug 11, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Sale and issuance of (i) convertible promissory notes, convertible into shares of Equity Securities, (ii) warrants exercisable for Series B Preferred Stock, and (iii) the underlying shares of common s
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Helen Jenkins · Executive Officer
  • Lee Rauch · Executive Officer, Director
  • Michael Kitt · Executive Officer
  • Paulette Dillon · Executive Officer
  • Tito Serafini · Executive Officer
  • Arlene Morris · Director
  • Joshua Funder · Director
  • Kim Kamdar · Director
  • Robert More · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Lee Rauch, President and CEO. Source: SEC Form D, newest notice filed Aug 11, 2010. Read the notice at the SEC.

debt, optionsSEC
Mar 2010$6 MNo. 2$2 to $10 million

NUON Therapeutics Inc.: Raise no. 2, Mar 2010

Investors in this round

6 investors had bought by the notice of Mar 17, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered; $0 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arlene Morris · Executive Officer, Director
  • Helen Jenkins · Executive Officer
  • Michael Kitt · Executive Officer
  • Joshua Funder · Director
  • Kim Kamdar · Director
  • Robert More · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $6,125,766.59, Total Amount Sold: $6,053,189.10, Total Remaining to be sold: $72,577.49”

Signed by Helen Jenkins, Executive Vice President, CFO and COO. Source: SEC Form D, newest notice filed Mar 17, 2010. Read the notice at the SEC.

equitySEC
Aug 2009$14 MNo. 1$10 to $50 million

NUON Therapeutics Inc.: Raise no. 1, Aug 2009

Investors in this round

0 investors had bought by the notice of Aug 25, 2009: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Rodney Pearlman · Executive Officer, Director
  • Arlene Morris · Director
  • Bob More · Director
  • Josh Funder · Director
  • Kim Kamdar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount: $13,662,500.42, Total Amount Sold: $13,662,500.42, Total Remaining to be sold: $0.00”

Signed by J. Casey McGlynn, Secretary. Source: SEC Form D, newest notice filed Aug 25, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NUON Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2010).

    SEC Form D · Aug 2010

  • The industry group it chose in its notices: Other.

    SEC Form D · Aug 2010

That is all the official record says: NUON Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NUON Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NUON Therapeutics Inc.
NameRoleNamed in
Helen JenkinsExecutive officerAug 2010
Lee RauchExecutive officerAug 2010
Michael KittExecutive officerAug 2010
Paulette DillonExecutive officerAug 2010
Tito SerafiniExecutive officerAug 2010
Arlene MorrisExecutive officerMar 2010
Rodney PearlmanExecutive officerAug 2009
Arlene MorrisDirectorAug 2010
Joshua FunderDirectorAug 2010
Kim KamdarDirectorAug 2010
Lee RauchDirectorAug 2010
Robert MoreDirectorAug 2010
Bob MoreDirectorAug 2009
Josh FunderDirectorAug 2009
Rodney PearlmanDirectorAug 2009